Weise W, Schönijahn A, Prügel P
Zentralbl Gynakol. 1982;104(1):2-8.
Combined oestrogen-gestagen preparations were applied to 169 women who had been sterile for an average period of 2.5 years, between 1975 and 1979. Their uncorrected pregnancy rate was 19 per cent. Pregnancy rates were 25 per cent for women who desired to have children up to two years or six per cent for those who tried longer. Oestrogen-gestagen therapy was successful in 20 per cent of women up to 30, but only in nine per cent of those beyond that age limit. Best therapeutic results were 45 per cent in cases of secondary amenorrhoea and 35 per cent in cases of genuine corpus luteum insufficiency. Anovulation, disorders of menstrual regularity, and Stein-Leventhal syndrome proved to be unfavourable conditions for this kind of therapy. The course of pregnancy was not accompanied by peculiarities of extraordinary dimensions. Combined oestrogen-gestagen treatment was found to be an appropriate initial therapy, within WHO Group II, for secondary (post-pill) amenorrhoea and corpus luteum insufficiency. While the presence of additional sterility factors does not necessarily mean contra-indication, prospects of success are reduced.
1975年至1979年间,对169名平均不孕2.5年的女性使用了雌激素 - 孕激素联合制剂。她们未经校正的妊娠率为19%。有生育意愿达两年的女性妊娠率为25%,而尝试时间更长的女性妊娠率为6%。30岁及以下的女性中,20%通过雌激素 - 孕激素治疗成功受孕,但30岁以上的女性中这一比例仅为9%。继发性闭经患者的最佳治疗效果为45%,真性黄体功能不全患者为35%。无排卵、月经周期紊乱和斯坦因 - 莱文塔尔综合征被证明对此类治疗不利。妊娠过程未出现异常特殊情况。对于继发性(停药后)闭经和黄体功能不全,雌激素 - 孕激素联合治疗被认为是世界卫生组织第二类中的一种合适的初始治疗方法。虽然存在其他不孕因素不一定意味着禁忌,但成功的可能性会降低。